{
    "organizations": [],
    "uuid": "4420b4694f7c3f749c629ae083b619b0e7075afa",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-karyopharm-announces-agreement-for/brief-karyopharm-announces-agreement-for-biogen-to-acquire-kpt-350-idUSASB0C2A7",
    "ord_in_thread": 0,
    "title": "BRIEF-Karyopharm Announces Agreement For Biogen To Acquire KPT-350",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Karyopharm Therapeutics Inc:\n* KARYOPHARM ANNOUNCES AGREEMENT FOR BIOGEN TO ACQUIRE KPT-350 FOR THE TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE CONDITIONS\n* KARYOPHARM THERAPEUTICS INC - DEAL VALUED AT UP TO $217 MILLION\n* KARYOPHARM THERAPEUTICS - ‚ÄçBIOGEN IS ACQUIRING KPT-350 AND OTHER ASSETS TARGETING CERTAIN NEUROLOGICAL CONDITIONS, INCLUDING ALS\n* KARYOPHARM - DEAL INCLUDES $10 MILLION UPFRONT PAYMENT TO KARYOPHARM, AND POTENTIAL $207 MILLION IN FUTURE MILESTONES, PLUS ROYALTIES\n* KARYOPHARM - CO ALSO ELIGIBLE TO GET TIERED ROYALTIES FROM BIOGEN THAT REACH LOW DOUBLE DIGITS BASED ON FUTURE NET SALES OF SOME PRODUCT CANDIDATES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-25T19:35:00.000+02:00",
    "crawled": "2018-01-26T21:29:00.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "karyopharm",
        "therapeutic",
        "inc",
        "karyopharm",
        "announces",
        "agreement",
        "biogen",
        "acquire",
        "treatment",
        "neurological",
        "neurodegenerative",
        "condition",
        "karyopharm",
        "therapeutic",
        "inc",
        "deal",
        "valued",
        "million",
        "karyopharm",
        "therapeutic",
        "acquiring",
        "asset",
        "targeting",
        "certain",
        "neurological",
        "condition",
        "including",
        "al",
        "karyopharm",
        "deal",
        "includes",
        "million",
        "upfront",
        "payment",
        "karyopharm",
        "potential",
        "million",
        "future",
        "milestone",
        "plus",
        "royalty",
        "karyopharm",
        "co",
        "also",
        "eligible",
        "get",
        "tiered",
        "royalty",
        "biogen",
        "reach",
        "low",
        "double",
        "digit",
        "based",
        "future",
        "net",
        "sale",
        "product",
        "candidate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}